The Michael J. Fox Foundation for Parkinson's Research is a nonprofit organization focused on accelerating the development of next-generation treatments and ultimately curing Parkinson's disease. By funding key research projects, promoting collaboration among scientists, and advocating for increased patient involvement in research, the Foundation is driving real progress towards better therapies and a cure.
2000
13-4141945
$397.8 million
This organization contributes to the following United Nations Sustainable Development Goals. See the SDG page for more information.
Stay updated with the latest developments in Parkinson's research through our regularly published news articles and updates. Learn about cutting-edge treatments and landmark studies shaping the field.
Participate in various events like marathons, golf outings, and community fundraisers organized by Team Fox members around the world. Your involvement helps raise critical funds for Parkinson's research.
The Fox Insight study invites individuals with Parkinson’s and their families to share their lived experiences and contribute to research. Over 48,000 participants have joined this online study, making significant contributions to the understanding of the disease.
Discovery of a Parkinson's Disease Biomarker
The Michael J. Fox Foundation played a pivotal role in the discovery of a biomarker that can detect Parkinson's disease pathology in living people, even before symptoms appear. This groundbreaking achievement accelerates the next stages of research and potential treatments.
Over $1 Billion Funded in Research
Since its inception, the Foundation has funded over $1 billion in research programs, significantly advancing the understanding and treatment of Parkinson's disease. This funding supports a wide range of projects from early-stage scientific discoveries to clinical trials.
06/24/2024
A successful golf tournament which raised funds for Parkinson's research and provided a fun, engaging event for participants.
06/30/2024
A concert dedicated to raising awareness and funds for Parkinson's disease, featuring various performances.
Overall Score
69
56
/100
Program Expense Ratio
90.69%
20
/20
Program Revenue Growth
0.00%
2
/20
Leverage Ratio
0.4872
8
/20
Working Capital Ratio
0.6019
8
/20
Fundraising Efficiency
0.3132
18
/20
Fiscal Year:2022
Source:Source: Self-reported by organization
Category | Amount | Percentage |
---|---|---|
Contributions, Gifts, and Grants | 358.3M | 98.87% |
Program Services | 0 | 0.00% |
Investment Income | 2.829M | 0.78% |
Sales of Non-Inventory Assets | -48.48K | -0.01% |
Other Notable Sources | 61.93K | 0.02% |
Total Revenue | 362.4M | 100.00% |
Med Research
Brain ResearchMed Research
Brain ResearchMed Research
Brain ResearchMed Research
Brain ResearchMed Research
Brain Research